Abstract:Objective To investigate the molecular mechanisms of cross-resistance to azoles in a clinical isolate of Aspergillus fumigatus. Methods A. fumigatus was isolated from a patient with invasive aspergillosis.Clinical Laboratory Standard Institute M38-A2 broth microdilution method and E-test method were used to determine the minimum inhibitory concentrations (MICs) or minimum effective concentration (MEC) of itraconazole, voriconazole, amphotericin B, posaconazole and caspofungin for the A. fumigatus isolate. DNA was extracted from the isolate and subjected to the amplification of cyp51A gene encoding the target enzyme of azole antifungal agents followed by sequence analysis. Results The broth microdilution test showed that the MEC of caspofungin was 0.5 mg/L, and MICs of itraconazole, voriconazole and amphotericin B were ≥ 16 mg/L,8 mg/L and 1 mg/L, respectively, for this isolate; while E-test assay revealed that the MICs of caspofungin,itraconazole, voriconazole, amphotericin B and posaconazole were 0.047 mg/L, ≥32 mg/L,≥32 mg/L, 12 mg/L and ≥32 mg/L, respectively. Sequence analysis showed an insertion of a 34-bp tandem sequence in the promoter region of the cyp51A gene as well as a T364A point mutation causing the substitution of leucine 98 (L98H). In addition, there were some other mutations in the cyp51A gene of this isolate, such as A137T,G585A, C814A, G836C, T991C and A1350G, which could result in corresponding amino acid substitutions.Conclusions An A. fumigatus strain with cross-resistance to azole antifungal agents is isolated. There is an insertion of a 34-bp tandem sequence into the promoter region as well as a T364A point mutation in the cyp51A gene, which contribute to the cross resistance to azole antifungal agents including itraconazole, voriconazole,and posaconazole. In addition, other mutations causing amino acid substitutions have also been detected in the cyp51 A gene of this isolate.

Deletion of cox7c Results in Pan-Azole Resistance in Aspergillus fumigatus

Mutation in Cyp51a and High Expression of Efflux Pump Gene of Aspergillus Fumigatus Induced by Propiconazole in Liquid Medium and Soil.

Increased Triazole-Resistance and Cyp51a Mutations in Aspergillus Fumigatus after Selection with a Combination of the Triazole Fungicides Difenoconazole and Propiconazole

Screening and Characterization of a Non- Cyp51a Mutation in an Aspergillus Fumigatus Cox10 Strain Conferring Azole Resistance

Uncovering New Mutations Conferring Azole Resistance in the Aspergillus Fumigatus Cyp51a Gene.

A ubiquitin-mediated post-translational degradation of Cyp51A contributes to a novel azole resistance mode in Aspergillus fumigatus

Gene Mutations and Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis.

Tebuconazole Induces Triazole-Resistance in Aspergillus Fumigatus in Liquid Medium and Soil.

Cyp51a-Based Mechanism of Azole Resistance in Aspergillus Fumigatus: Illustration by A New 3d Structural Model of Aspergillus Fumigatus Cyp51a Protein

Multiple cyp51A-Based Mechanisms Identified in Azole-Resistant Isolates of Aspergillus fumigatus from China.

Discovery of a HapE mutation that causes azole resistance in Aspergillus fumigatus through whole genome sequencing and sexual crossing

Mitochondrial Membrane-Associated Protein Mba1 Confers Antifungal Resistance by Affecting the Production of Reactive Oxygen Species in Aspergillus Fumigatus.

cyp51A mutations, protein modeling, and efflux pump gene expression reveals multifactorial complexity towards understanding Aspergillus section Nigri azole resistance mechanism

The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus

Molecular mechanisms of cross-resistance to azole antifungal agents in a clinical isolate of Aspergillus fumigatus: a preliminary study

The cytochrome P450 reductase CprA is a rate-limiting factor for Cyp51A-mediated azole resistance in Aspergillus fumigatus

Contribution of NADPH-cytochrome P450 Reductase to Azole Resistance in Fusarium Oxysporum

Azole resistance in a clinical isolate of Aspergillus fumigatus from Chile

Epidemiology and Molecular Characterizations of Azole Resistance in Clinical and Environmental Aspergillus Fumigatus Isolates from China.

Mutations in the Cyp51A Gene and Susceptibility to Itraconazole in Aspergillus Fumigatus Isolated from Avian Farms in France and China

Five-Year Survey (2014 to 2018) of Azole Resistance in Environmental Aspergillus Fumigatus Isolates from China.